Movement Alert|Baxter International Falls 5.14% in Regular Trading, Goldman Sachs Raises Target but Maintains Neutral as Sector Sells Off

Market Focus07-14

On July 14, Baxter International fell 5.14% in regular trading, trading at $21.40/share, with turnover of $19.65 million.

On the news front, Goldman Sachs raised its price target on Baxter International from $19 to $21 while maintaining a Neutral rating. However, the updated target remains near the current trading level, signaling limited upside potential. The consensus mean price target stands at $20.10 with an average Hold rating, reflecting broad institutional caution on the stock.

The broader Health Care Equipment sector experienced significant selling pressure on the same day. Among sector peers, Stryker fell 5.99%, Intuitive Surgical declined 4.0%, Medtronic dropped 4.0%, Boston Scientific lost 3.74%, and Abbott Laboratories fell 2.61%. The combination of sector-wide weakness and a cautious analyst stance weighed heavily on Baxter International shares.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment